Halma plc (LSE:HLMA) acquired NovaBone Products, LLC for $97 million on January 24, 2020. The cash consideration of $97 million is paid on a cash and debt free basis. The acquisition is funded from Halma's existing facilities. In addition, the consideration, an earn-out is payable in cash, dependent on profit growth in each of the two financial years to March 2022, up to an aggregate maximum of $40 million, with a maximum of $25 million achievable in any single financial year. Upon completion, NovaBone Products will become part of Halma's medical sector. Manish Gupta, Rob Andrews and David Silver of Robert W. Baird & Co. Incorporated acted as financial advisor to NovaBone Products, LLC. Halma plc (LSE:HLMA) completed the acquisition of NovaBone Products, LLC on January 24, 2020.